Privacy Policy

Last updated: June 1, 2021

Our mobile applications (apps) provide self-help, education and support. This App is a treatment companion for use by a health care professional to make treatment easier. There are apps for iOS and Android devices. Opioid Use Disorder is a serious mental health condition that needs professional evaluation and treatment. These apps are not intended to replace needed professional care.

No individually identifiable data is transferred or transmitted to Yale in any way through the use of the app. All individually identifiable data entered by you remains your sole property and will not be accessed by Yale without your further express consent. You also acknowledge that it is your sole responsibility to protect and otherwise secure any information captured and stored by the software once installed on your device. For statistical purposes Yale collects anonymous usage data and sends it to a data provider. This feature can be disabled through the app's settings screen at any time.

This app is meant to be used by a medical professional and is not intended to guide self-assessment or take the place of a healthcare provider’s clinical judgment. Patients taking methadone may have withdrawal reactions to buprenorphine up to 72 hours after last use. Consider consultation before starting buprenorphine in these patients. All patients should be educated regarding dangers of benzodiazepine and alcohol co-use. For pregnant patients, consider use of buprenorphine alone (not as combined product with naloxone). Whenever possible, provide a warm hand-off with specific date and time of follow-up appointment within 3-7 days for ongoing treatment with a community provider of medication for OUD.